Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

María Isabel Benítez‐Carabante, Cristina Díaz de Heredia, Ivan Lopez et al.|Transplantation and Cellular Therapy|2024

Cited by 13